CLEVELAND, OH — The age/sex/gene-expression score (ASGES) test known as Corus CAD (CardioDx) appears easy to incorporate and effective in excluding obstructive coronary artery disease (CAD) in ...

Coverage of Blood-Based Test Has Potential to Improve Quality of Care and Lower Costs of Diagnosis of Obstructive Coronary Artery Disease Beyond Traditional Methods PALO ALTO, Calif. – CardioDx, Inc., ...

PALO ALTO, CA--(Marketwired - Mar 10, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of the IMPACT-PCP (Investigation ...

CHICAGO — In stable symptomatic patients with suspected CAD, a precision testing strategy was linked to a 70% reduction in death, MI or catheterization without obstructive CAD at 1 year compared with ...

Dr. Merle C. Turner, Medical Director of Warner Family Practice in Chandler, Arizona, discusses his perspective on the benefits of the CORUS CAD genomic test in determining whether or not a patient ...

Dr. Topol is senior author of: Rosenberg S, Elashoff MR, Beineke B, et al; PREDICT (Personalized Risk Evaluation and Diagnosis in the Coronary Tree) Investigators. Multicenter validation of the ...

Coronary artery disease is a serious but common type of heart disease that can lead to heart attacks. A recent study suggests that measuring levels of apolipoprotein B particles and lipoprotein(a) ...